Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88315073 |
LAW OFFICE ASSIGNED |
LAW OFFICE 117 |
MARK SECTION |
MARK |
http://uspto.report/TM/88315073/mark.png (stylized and/or with design) |
STANDARD CHARACTERS |
NO |
USPTO-GENERATED IMAGE |
NO |
OWNER SECTION (current) |
NAME |
Kite Pharma, Inc. |
MAILING ADDRESS |
2400 Broadway |
CITY |
Santa Monica |
STATE |
California |
ZIP/POSTAL CODE |
90404 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
312 368 7025 |
FAX |
312 236 7516 |
EMAIL |
XXXX |
OWNER SECTION (proposed) |
NAME |
Kite Pharma, Inc. |
MAILING ADDRESS |
2400 Broadway |
CITY |
Santa Monica |
STATE |
California |
ZIP/POSTAL CODE |
90404 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
(312) 372-2000 |
FAX |
(312) 984-7700 |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
Christina L. Martini |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
ipdocketmwe@mwe.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
cmartini@mwe.com; lgrabowski@mwe.com; trademarks@gilead.com; ipdocketchicago@mwe.com |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Christina L. Martini |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
ipdocketmwe@mwe.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
cmartini@mwe.com; lgrabowski@mwe.com; trademarks@gilead.com; ipdocketchicago@mwe.com |
DOCKET/REFERENCE NUMBER |
106063-0920 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for immunotherapy,
including T Cell therapy |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
036 |
CURRENT IDENTIFICATION |
Financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
040 |
CURRENT IDENTIFICATION |
Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
044 |
CURRENT IDENTIFICATION |
Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory
services; collection and preservation of biological tissue, blood and cells |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
045 |
CURRENT IDENTIFICATION |
Providing patient advocate services in the field of the treatment of diseases and disorders |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
08/20/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
5 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
625 |
TOTAL AMOUNT |
625 |
SIGNATURE SECTION |
SIGNATURE |
/Gretchen Stroud/ |
SIGNATORY'S NAME |
Gretchen R. Stroud |
SIGNATORY'S POSITION |
Head of Trademarks |
DATE SIGNED |
07/09/2020 |
FILING INFORMATION |
SUBMIT DATE |
Thu Jul 09 12:02:26 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XX.XXX.XXX-2
0200709120226261633-88315
073-710b02013df87e78a916b
d61e4cdb33f5d423d88b7e583
86a207996d0e7667b-DA-0225
8128-20200708150652869856 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: KITE (stylized and/or with design, see http://uspto.report/TM/88315073/mark.png)
SERIAL NUMBER: 88315073
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Kite Pharma, Inc., having an address of
2400 Broadway
Santa Monica, California 90404
United States
Phone: 312 368 7025
Fax: 312 236 7516
Email: XXXX
Proposed: Kite Pharma, Inc., having an address of
2400 Broadway
Santa Monica, California 90404
United States
Phone: (312) 372-2000
Fax: (312) 984-7700
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 08/20/2019.
For International Class 005:
Current identification: Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical preparations for immunotherapy, including T Cell therapy
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 036:
Current identification: Financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 040:
Current identification: Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 044:
Current identification: Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; collection and
preservation of biological tissue, blood and cells
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 045:
Current identification: Providing patient advocate services in the field of the treatment of diseases and disorders
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
Correspondence Information (current):
Christina L. Martini
PRIMARY EMAIL FOR CORRESPONDENCE: ipdocketmwe@mwe.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): cmartini@mwe.com; lgrabowski@mwe.com; trademarks@gilead.com; ipdocketchicago@mwe.com
Correspondence Information (proposed):
Christina L. Martini
PRIMARY EMAIL FOR CORRESPONDENCE: ipdocketmwe@mwe.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): cmartini@mwe.com; lgrabowski@mwe.com; trademarks@gilead.com; ipdocketchicago@mwe.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $625 will be submitted with the form, representing payment for 5 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Gretchen Stroud/ Date Signed: 07/09/2020
Signatory's Name: Gretchen R. Stroud
Signatory's Position: Head of Trademarks
RAM Sale Number: 88315073
RAM Accounting Date: 07/09/2020
Serial Number: 88315073
Internet Transmission Date: Thu Jul 09 12:02:26 ET 2020
TEAS Stamp: USPTO/ESU-XX.XX.XXX.XXX-2020070912022626
1633-88315073-710b02013df87e78a916bd61e4
cdb33f5d423d88b7e58386a207996d0e7667b-DA
-02258128-20200708150652869856